Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004

The food supply, including poultry products, may transmit antimicrobial drug–resistant Escherichia coli to humans. To assess this hypothesis, 931 geographically and temporally matched E. coli isolates from human volunteers (hospital inpatients and healthy vegetarians) and commercial poultry products...

Full description

Bibliographic Details
Main Authors: James R. Johnson, Mark R. Sannes, Cynthia Croy, Brian Johnston, Connie Clabots, Michael A. Kuskowski, Jeff Bender, Kirk E. Smith, Patricia L. Winokur, Edward A. Belongia
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2007-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/13/6/06-1576_article
_version_ 1811280334353858560
author James R. Johnson
Mark R. Sannes
Cynthia Croy
Brian Johnston
Connie Clabots
Michael A. Kuskowski
Jeff Bender
Kirk E. Smith
Patricia L. Winokur
Edward A. Belongia
author_facet James R. Johnson
Mark R. Sannes
Cynthia Croy
Brian Johnston
Connie Clabots
Michael A. Kuskowski
Jeff Bender
Kirk E. Smith
Patricia L. Winokur
Edward A. Belongia
author_sort James R. Johnson
collection DOAJ
description The food supply, including poultry products, may transmit antimicrobial drug–resistant Escherichia coli to humans. To assess this hypothesis, 931 geographically and temporally matched E. coli isolates from human volunteers (hospital inpatients and healthy vegetarians) and commercial poultry products (conventionally raised or raised without antimicrobial drugs) were tested by PCR for phylogenetic group (A, B1, B2, D) and 60 virulence genes associated with extraintestinal pathogenic E. coli. Isolates resistant to trimethoprim-sulfamethoxazole, quinolones, and extended-spectrum cephalosporins (n = 331) were compared with drug-susceptible isolates (n = 600) stratified by source. Phylogenetic and virulence markers of drug-susceptible human isolates differed considerably from those of human and poultry isolates. In contrast, drug-resistant human isolates were similar to poultry isolates, and drug-susceptible and drug-resistant poultry isolates were largely indistinguishable. Many drug-resistant human fecal E. coli isolates may originate from poultry, whereas drug-resistant poultry-source E. coli isolates likely originate from susceptible poultry-source precursors.
first_indexed 2024-04-13T01:11:48Z
format Article
id doaj.art-0b5b7e948e0b4d57bfa623f168e66602
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-04-13T01:11:48Z
publishDate 2007-06-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-0b5b7e948e0b4d57bfa623f168e666022022-12-22T03:09:07ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592007-06-0113683883810.3201/eid1306.061576Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004James R. JohnsonMark R. SannesCynthia CroyBrian JohnstonConnie ClabotsMichael A. KuskowskiJeff BenderKirk E. SmithPatricia L. WinokurEdward A. BelongiaThe food supply, including poultry products, may transmit antimicrobial drug–resistant Escherichia coli to humans. To assess this hypothesis, 931 geographically and temporally matched E. coli isolates from human volunteers (hospital inpatients and healthy vegetarians) and commercial poultry products (conventionally raised or raised without antimicrobial drugs) were tested by PCR for phylogenetic group (A, B1, B2, D) and 60 virulence genes associated with extraintestinal pathogenic E. coli. Isolates resistant to trimethoprim-sulfamethoxazole, quinolones, and extended-spectrum cephalosporins (n = 331) were compared with drug-susceptible isolates (n = 600) stratified by source. Phylogenetic and virulence markers of drug-susceptible human isolates differed considerably from those of human and poultry isolates. In contrast, drug-resistant human isolates were similar to poultry isolates, and drug-susceptible and drug-resistant poultry isolates were largely indistinguishable. Many drug-resistant human fecal E. coli isolates may originate from poultry, whereas drug-resistant poultry-source E. coli isolates likely originate from susceptible poultry-source precursors.https://wwwnc.cdc.gov/eid/article/13/6/06-1576_articleEscherichia coli infectionsantimicrobial drug resistancevirulencephylogeneticsPCRmolecular fingerprinting
spellingShingle James R. Johnson
Mark R. Sannes
Cynthia Croy
Brian Johnston
Connie Clabots
Michael A. Kuskowski
Jeff Bender
Kirk E. Smith
Patricia L. Winokur
Edward A. Belongia
Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
Emerging Infectious Diseases
Escherichia coli infections
antimicrobial drug resistance
virulence
phylogenetics
PCR
molecular fingerprinting
title Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
title_full Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
title_fullStr Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
title_full_unstemmed Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
title_short Antimicrobial Drug–Resistant Escherichia coli from Humans and Poultry Products, Minnesota and Wisconsin, 2002–2004
title_sort antimicrobial drug resistant escherichia coli from humans and poultry products minnesota and wisconsin 2002 2004
topic Escherichia coli infections
antimicrobial drug resistance
virulence
phylogenetics
PCR
molecular fingerprinting
url https://wwwnc.cdc.gov/eid/article/13/6/06-1576_article
work_keys_str_mv AT jamesrjohnson antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT markrsannes antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT cynthiacroy antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT brianjohnston antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT connieclabots antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT michaelakuskowski antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT jeffbender antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT kirkesmith antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT patricialwinokur antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004
AT edwardabelongia antimicrobialdrugresistantescherichiacolifromhumansandpoultryproductsminnesotaandwisconsin20022004